Insulet

#Diabetes #Insulin Delivery #Chronic Disease Management

Insulet Corporation is a medical device company best known for its Omnipod insulin management system, the only tubeless insulin pump available in the U.S. Insulet is expanding into adjacent chronic disease management through technology partnerships.

Company Info

Sector:Medical Devices / Diabetes

Headquarters:Acton, Massachusetts, USA

Founded:2000

Website:www.omnipod.com/

Upcoming Milestones & Key Dates

2026-Q4

Commercial

Continued U.S. and international Omnipod 5 rollout

Clinical Development Pipeline

Omnipod 5

Target: Tubeless insulin pump with CGM integration

Type 1 and Type 2 diabetes (automated insulin delivery)

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Omnipod 5 + Abbott FreeStyle Libre integration

Target: iCGM-compatible tubeless pump

Type 1 diabetes

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Omnipod for GLP-1 users

Target: Insulin pump for combination therapy

Type 2 diabetes on GLP-1 therapy

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Insulet, Calm to fill mental health gaps in diabetes treatment ↗

Insulet, Calm to fill mental health gaps in diabetes treatment

Leadership Team

Jim Hollingshead

President & CEO

Wayde McMillan

Chief Financial Officer

Eric Benjamin

EVP, Innovation & Strategy

Careers & Job Openings

See all open roles

Multiple Departments

Acton, Massachusetts, USA

Apply Now →